Pluristem Therapeutics Inc.
(NASDAQ : PSTI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.36%176.931.2%$602.97m
GILDGilead Sciences, Inc.
-0.52%67.670.9%$539.66m
BIIBBiogen Inc.
-0.09%280.161.2%$518.85m
CELGCelgene Corporation
-3.59%75.561.2%$495.29m
REGNRegeneron Pharmaceuticals, Inc.
-1.60%296.982.6%$311.73m
ALXNAlexion Pharmaceuticals, Inc.
-1.74%118.972.0%$248.86m
ILMNIllumina, Inc.
-0.16%269.243.5%$243.93m
VRTXVertex Pharmaceuticals Incorporated
-0.39%156.631.9%$235.62m
NKTRNektar Therapeutics
-1.41%84.106.0%$209.20m
AAgilent Technologies, Inc.
2.18%65.731.5%$203.42m
INCYIncyte Corporation
-0.56%67.452.5%$193.42m
SRPTSarepta Therapeutics, Inc.
-3.09%90.5916.6%$127.23m
EXASExact Sciences Corporation
-0.19%52.2625.5%$115.84m
BMRNBioMarin Pharmaceutical Inc.
0.59%89.404.4%$115.10m
ALNYAlnylam Pharmaceuticals, Inc
-1.71%101.059.8%$101.89m

Company Profile

Pluristem Therapeutics, Inc. is a biotechnology company, which engages in the provision of cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others. Its products include PLacental eXpanded, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.